Home / Countries / Germany / HIV medicines

Germany · availability and reimbursement

HIV medicines in Germany

Of 26 verified HIV medicine records for Germany, 24 are available and reimbursed (92%), 0 are available but not reimbursed and 2 are not available. 16 further records are still under review.

92% of verified records reimbursed

Last checked 14/09/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 24

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Odefsey, Pifeltro, Prezista, Rekambys, Rukobia, Sunlenca, Symtuza, Tivicay, Triumeq, Truvada, Vocabria, Vocabria / Rekambys

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 16

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Emtriva, Epivir, Eviplera, Evotaz, Kivexa, Norvir, Retrovir, Reyataz, Rezolsta, Stribild, Viread, Yeytuo, Ziagen

See every medicine with its source →

More about Germany

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Germany profile

Neighbouring countries

SwitzerlandPolandNetherlandsLuxembourgFranceDenmarkCzechiaBelgium

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.